|
|
||||||||
1 Department of Nuclear Medicine, Ludwig-Maximilians-University of Munich,
Ziemssenstr. 1, D-80336 Munich, Germany.
2 Institute for Clinical Radiology, Ludwig-Maximilians-University of Munich,
Ziemssenstr. 1, D-80336 Munich, Germany.
3 Department of Pediatrics, Dr. von Haunersches Kinderspital,
Ludwig-Maximilians-University of Munich, Lindwurmstr. 4, D-80337 Munich,
Germany.
OBJECTIVE. The objectives of this study were to compare MRI and iodine-123 (123I) metaiodobenzylguanidine (MIBG) scintigraphy in the detection of neuroblastoma lesions in pediatric patients and to assess the additional value of combined imaging.
MATERIALS AND METHODS. Fifty MRI and 50 123I MIBG examinations (mean interval, 6.4 days) were analyzed retrospectively with regard to suspected or proven neuroblastoma lesions (n = 193) in 28 patients. MRI and MIBG scans were reviewed by two independent observers each. Separate and combined analyses of MRI and MIBG scintigraphy were compared with clinical and histologic findings.
RESULTS. With regard to the diagnosis of neuroblastoma lesion, MIBG scintigraphy, MRI, and combined analysis showed a sensitivity of 69%, 86%, and 99% and a specificity of 85%, 77%, and 95%, respectively. On MRI, 15 false-positive findings were recorded: posttherapeutic reactive changes (n = 10), benign adrenal tumors (n = 3), and enlarged lymph nodes (n = 2). On MIBG scintigraphy, 10 false-positive findings occurred: ganglioneuromas (n = 2), benign liver tumors (n = 2), and physiologic uptake (n = 6). Thirteen neuroblastoma metastases and two residual masses under treatment with chemotherapy were judged to be false-negative findings on MRI. Two primary or residual neuroblastomas and one orbital metastasis were misinterpreted as Wilms' tumor, reactive changes after surgery, and rhabdomyosarcoma on MRI. Thirty-two bone metastases, six other neuroblastoma metastases, and one adrenal neuroblastoma showed no MIBG uptake. On combined imaging, one false-negative (bone metastasis) and three false-positive (two ganglioneuromas and one pheochromocytoma) findings remained.
CONCLUSION. In the assessment of neuroblastoma lesions in pediatric patients, MRI showed a higher sensitivity and MIBG scintigraphy a higher specificity. However, integrated imaging showed an increase in both sensitivity and specificity.
![]()
CiteULike
Complore
Connotea
Del.icio.us
Digg
Reddit
Technorati What's this?
This article has been cited by other articles:
![]() |
C. Franzius, K. Hermann, M. Weckesser, K. Kopka, K. U. Juergens, J. Vormoor, and O. Schober Whole-Body PET/CT with 11C-Meta-Hydroxyephedrine in Tumors of the Sympathetic Nervous System: Feasibility Study and Comparison with 123I-MIBG SPECT/CT J. Nucl. Med., October 1, 2006; 47(10): 1635 - 1642. [Abstract] [Full Text] [PDF] |
||||
![]() |
W H van Houtum, E P M Corssmit, P B Douwes Dekker, J C Jansen, A G L van der Mey, A H J T Brocker-Vriends, P E M Taschner, M Losekoot, M Frolich, M P M Stokkel, et al. Increased prevalence of catecholamine excess and phaeochromocytomas in a well-defined Dutch population with SDHD-linked head and neck paragangliomas Eur. J. Endocrinol., January 1, 2005; 152(1): 87 - 94. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. M. Elsayes, G. Mukundan, V. R. Narra, J. S. Lewis Jr, A. Shirkhoda, A. Farooki, and J. J. Brown Adrenal Masses: MR Imaging Features with Pathologic Correlation RadioGraphics, October 1, 2004; 24(suppl_1): S73 - S86. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. H. Kushner Neuroblastoma: A Disease Requiring a Multitude of Imaging Studies J. Nucl. Med., July 1, 2004; 45(7): 1172 - 1188. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |